Literature DB >> 25648641

Gastrointestinal Manifestations of Cystic Fibrosis.

Thomas Kelly1, James Buxbaum.   

Abstract

Gastrointestinal symptoms of cystic fibrosis are the most important non-pulmonary manifestations of this genetic illness. Pancreatic manifestations include acute and chronic pancreatitis as well as pancreas insufficiency resulting in malnutrition. Complications in the gastrointestinal lumen are diverse and include distal intestinal obstruction syndrome (DIOS), meconium ileus, intussusception, and constipation; biliary tract complications include focal biliary cirrhosis and cholangiectasis. The common pathophysiology is the inspissation of secretions in the hollow structures of the gastrointestinal tract. Improved survival of CF patients mandates that the adult gastroenterologist be aware of the presentation and treatment of pancreatic, luminal, and hepatobiliary CF complications.

Entities:  

Mesh:

Year:  2015        PMID: 25648641     DOI: 10.1007/s10620-015-3546-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  85 in total

Review 1.  A review of abdominal organ transplantation in cystic fibrosis.

Authors:  Brandy R Lu; Carlos O Esquivel
Journal:  Pediatr Transplant       Date:  2010-10-14

Review 2.  Gastroesophageal reflux and respiratory disease in children.

Authors:  S R Orenstein; D M Orenstein
Journal:  J Pediatr       Date:  1988-06       Impact factor: 4.406

3.  Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.

Authors:  Kris De Boeck; Matijn Weren; Marijka Proesmans; Eitan Kerem
Journal:  Pediatrics       Date:  2005-03-16       Impact factor: 7.124

4.  Biliary tree in cystic fibrosis. Biliary tract abnormalities in cystic fibrosis demonstrated by endoscopic retrograde cholangiography.

Authors:  S Bass; J J Connon; C S Ho
Journal:  Gastroenterology       Date:  1983-06       Impact factor: 22.682

Review 5.  Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients.

Authors:  Carla Colombo; Helmut Ellemunter; Roderick Houwen; Anne Munck; Chris Taylor; Michael Wilschanski
Journal:  J Cyst Fibros       Date:  2011-06       Impact factor: 5.482

6.  The spectrum of appendiceal disease in cystic fibrosis.

Authors:  J P Coughlin; M W Gauderer; R C Stern; C F Doershuk; R J Izant; R M Zollinger
Journal:  J Pediatr Surg       Date:  1990-08       Impact factor: 2.545

Review 7.  The adult cystic fibrosis patient with abdominal pain: what the radiologist needs to know.

Authors:  S Y Liong; D Awad; A M Jones; S A Sukumar
Journal:  Clin Radiol       Date:  2010-11-20       Impact factor: 2.350

8.  Management and survival of meconium ileus. A 30-year review.

Authors:  C A Del Pin; C Czyrko; M M Ziegler; T F Scanlin; H C Bishop
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

9.  Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model.

Authors:  S E Gabriel; K N Brigman; B H Koller; R C Boucher; M J Stutts
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

10.  Genetic modifiers of liver disease in cystic fibrosis.

Authors:  Jaclyn R Bartlett; Kenneth J Friedman; Simon C Ling; Rhonda G Pace; Scott C Bell; Billy Bourke; Giuseppe Castaldo; Carlo Castellani; Marco Cipolli; Carla Colombo; John L Colombo; Dominique Debray; Adriana Fernandez; Florence Lacaille; Milan Macek; Marion Rowland; Francesco Salvatore; Christopher J Taylor; Claire Wainwright; Michael Wilschanski; Dana Zemková; William B Hannah; M James Phillips; Mary Corey; Julian Zielenski; Ruslan Dorfman; Yunfei Wang; Fei Zou; Lawrence M Silverman; Mitchell L Drumm; Fred A Wright; Ethan M Lange; Peter R Durie; Michael R Knowles
Journal:  JAMA       Date:  2009-09-09       Impact factor: 56.272

View more
  26 in total

1.  Colocolonic intussusception in an adult cystic fibrosis patient.

Authors:  Adegboyega Timothy Adewale; Steven M Rowe; George M Solomon
Journal:  J Cyst Fibros       Date:  2018-11-29       Impact factor: 5.482

Review 2.  Hyperinflammation and airway surface liquid dehydration in cystic fibrosis: purinergic system as therapeutic target.

Authors:  Thiago Inácio Teixeira do Carmo; Victor Emanuel Miranda Soares; Jonatha Wruck; Fernanda Dos Anjos; Débora Tavares de Resende E Silva; Sarah Franco Vieira de Oliveira Maciel; Margarete Dulce Bagatini
Journal:  Inflamm Res       Date:  2021-04-27       Impact factor: 4.575

3.  Validity and Reliability of a Novel Multimodal Questionnaire for the Assessment of Abdominal Symptoms in People with Cystic Fibrosis (CFAbd-Score).

Authors:  Anke Jaudszus; Elisa Zeman; Tatjana Jans; Elena Pfeifer; Harold Tabori; Christin Arnold; Ruth K Michl; Michael Lorenz; Natalie Beiersdorf; Jochen G Mainz
Journal:  Patient       Date:  2019-08       Impact factor: 3.883

4.  Abdominal Pain in a 17-Year-Old Girl With Pancreatic Insufficient Cystic Fibrosis.

Authors:  Alyssa R Wojciechowski; Carlye T Tomczyk; Theresa A Laguna
Journal:  Clin Pediatr (Phila)       Date:  2016-07-19       Impact factor: 1.168

5.  Lubiprostone is non-selective activator of cAMP-gated ion channels and Clc-2 has a minor role in its prosecretory effect in intestinal epithelial cells.

Authors:  Apurva A Oak; Tifany Chu; Pattareeya Yottasan; Parth D Chhetri; Jie Zhu; Justin Du Bois; Onur Cil
Journal:  Mol Pharmacol       Date:  2022-06-09       Impact factor: 4.054

Review 6.  Meconium Ileus.

Authors:  John H T Waldhausen; Morgan Richards
Journal:  Clin Colon Rectal Surg       Date:  2018-02-25

7.  Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.

Authors:  Andrea Gini; Ann G Zauber; Dayna R Cenin; Amir-Houshang Omidvari; Sarah E Hempstead; Aliza K Fink; Albert B Lowenfels; Iris Lansdorp-Vogelaar
Journal:  Gastroenterology       Date:  2017-11-02       Impact factor: 22.682

Review 8.  Ion channelopathies in functional GI disorders.

Authors:  Arthur Beyder; Gianrico Farrugia
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-11       Impact factor: 4.052

Review 9.  Role of inflammation and oxidative stress in tissue damage associated with cystic fibrosis: CAPE as a future therapeutic strategy.

Authors:  Victor Emanuel Miranda Soares; Thiago Inácio Teixeira do Carmo; Fernanda Dos Anjos; Jonatha Wruck; Sarah Franco Vieira de Oliveira Maciel; Margarete Dulce Bagatini; Débora Tavares de Resende E Silva
Journal:  Mol Cell Biochem       Date:  2021-09-16       Impact factor: 3.396

10.  SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine.

Authors:  Onur Cil; Peter M Haggie; Joseph-Anthony Tapia Tan; Amber A Rivera; Alan S Verkman
Journal:  JCI Insight       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.